510(k) Report

510(k) · Cleared

Cleared

Euroimmun Anti-M2-3E Elisa (Igg)

K092736510(k) TraditionalCleared Sep 2, 2010363-day reviewClass II21 CFR 866.5090

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Euroimmun Us, Inc. · DBM Antimitochondrial Antibody, Indirect Immunofluorescent, Antigen, Control

Cleared on Sep 2, 2010 as substantially equivalent to K052262 (Inova Diagnostics, Inc., 2005) after a 363-day review. Its family tree reaches back 1 generation to 2005.

Decided
Sep 2, 2010
Review
363 days
Class
Class II
Product code
DBM
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K052262 (2005). No later device cites it as a predicate yet.

K052262 · Quanta Lite M2 EP (MIT3) Elisa · Inova Diagnostics, Inc. · 20052006200820102012
  1. Root · 1 generation backK052262 Quanta Lite M2 EP (MIT3) ElisaInova Diagnostics, Inc. · 2005
  2. This deviceK092736 Euroimmun Anti-M2-3E Elisa (Igg)Euroimmun Us, Inc. · 2010
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K052262Quanta Lite M2 EP (MIT3) ElisaInova Diagnostics, Inc.2005—
0 (this device)K092736Euroimmun Anti-M2-3E Elisa (Igg)Euroimmun Us, Inc.2010—
FIG. 1 — Lineage of K092736, 2005–2010Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DBM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K052262Quanta Lite M2 EP (MIT3) Elisa
Summary page 2
…ence Information: 1. Predicate device name (s): Inova Quanta Lite M2 EP (MIT3) ELISA 2. Predicate 510(k) number(s): K052262 3. Comparison with Predicate: Similarities Item New Device…
Inova Diagnostics, Inc.2005—

Also cleared against K052262: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 3 other devices also cite its predicate K052262.

How does its category compare?

All DBM devices

DBM Antimitochondrial Antibody, Indirect Immunofluorescent, Antigen, Control: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · DBM

1in 2018

2010: 12015: 12017: 22018: 1
2007high 2 (2017) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DBM

Too few DBM 510(k)s in any year since 2007 to give a median.

Recalls per year · DBM

1in 2008

2008: 1
2007high 1 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DBM

1in 2018

2018: 1
2007high 1 (2018) · low 0 (2007)2025

MAUDE reports naming product code DBM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—10
20090—00
20101—00
20110—00
20120—00
20130—00
20140—00
20151—00
20160—00
20172—00
20181—01
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The EUROIMMUN Anti-M2-3E ELISA (IgG) test kit is intended for the qualitative or semi-quantitative determination of lgG class autoantibodies against the mitochondrial antigens M2 in human serum and plasma. It is used as an aid in the diagnosis of primary biliary cirrhosis (PBC), in conjunction with other laboratory and clinical findings.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K092736: Euroimmun Anti-M2-3E Elisa (Igg).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K092736

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026